List of Tables
Table 1. Haemophilia Drug Market Trends
Table 2. Haemophilia Drug Market Drivers & Opportunity
Table 3. Haemophilia Drug Market Challenges
Table 4. Haemophilia Drug Market Restraints
Table 5. Global Haemophilia Drug Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Haemophilia Drug Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Haemophilia Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Haemophilia Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Haemophilia Drug
Table 10. Global Haemophilia Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilia Drug as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Haemophilia Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Haemophilia Drug Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Haemophilia Drug Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Haemophilia Drug Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Haemophilia Drug Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Haemophilia Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Haemophilia Drug Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Haemophilia Drug Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Haemophilia Drug Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Haemophilia Drug Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Haemophilia Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Haemophilia Drug Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Haemophilia Drug Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Haemophilia Drug Sales Value by Region (2019-2024) & (%)
Table 27. Global Haemophilia Drug Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Haemophilia Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Haemophilia Drug Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Haemophilia Drug Sales Value, (2025-2030) & (US$ Million)
Table 31. Shire (Baxter) Basic Information List
Table 32. Shire (Baxter) Description and Business Overview
Table 33. Shire (Baxter) Haemophilia Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Haemophilia Drug Business of Shire (Baxter) (2019-2024)
Table 35. Shire (Baxter) Recent Developments
Table 36. CSL Basic Information List
Table 37. CSL Description and Business Overview
Table 38. CSL Haemophilia Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Haemophilia Drug Business of CSL (2019-2024)
Table 40. CSL Recent Developments
Table 41. Grifols Basic Information List
Table 42. Grifols Description and Business Overview
Table 43. Grifols Haemophilia Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Haemophilia Drug Business of Grifols (2019-2024)
Table 45. Grifols Recent Developments
Table 46. Biogen Basic Information List
Table 47. Biogen Description and Business Overview
Table 48. Biogen Haemophilia Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Haemophilia Drug Business of Biogen (2019-2024)
Table 50. Biogen Recent Developments
Table 51. Octapharma Basic Information List
Table 52. Octapharma Description and Business Overview
Table 53. Octapharma Haemophilia Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Haemophilia Drug Business of Octapharma (2019-2024)
Table 55. Octapharma Recent Developments
Table 56. Kedrion Basic Information List
Table 57. Kedrion Description and Business Overview
Table 58. Kedrion Haemophilia Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Haemophilia Drug Business of Kedrion (2019-2024)
Table 60. Kedrion Recent Developments
Table 61. BPL Basic Information List
Table 62. BPL Description and Business Overview
Table 63. BPL Haemophilia Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Haemophilia Drug Business of BPL (2019-2024)
Table 65. BPL Recent Developments
Table 66. Bayer Basic Information List
Table 67. Bayer Description and Business Overview
Table 68. Bayer Haemophilia Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Haemophilia Drug Business of Bayer (2019-2024)
Table 70. Bayer Recent Developments
Table 71. Novo Nordisk Basic Information List
Table 72. Novo Nordisk Description and Business Overview
Table 73. Novo Nordisk Haemophilia Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Haemophilia Drug Business of Novo Nordisk (2019-2024)
Table 75. Novo Nordisk Recent Developments
Table 76. Pfizer Basic Information List
Table 77. Pfizer Description and Business Overview
Table 78. Pfizer Haemophilia Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Haemophilia Drug Business of Pfizer (2019-2024)
Table 80. Pfizer Recent Developments
Table 81. Roche Basic Information List
Table 82. Roche Description and Business Overview
Table 83. Roche Haemophilia Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Haemophilia Drug Business of Roche (2019-2024)
Table 85. Roche Recent Developments
Table 86. Baxter Basic Information List
Table 87. Baxter Description and Business Overview
Table 88. Baxter Haemophilia Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Haemophilia Drug Business of Baxter (2019-2024)
Table 90. Baxter Recent Developments
Table 91. Sinopharm Basic Information List
Table 92. Sinopharm Description and Business Overview
Table 93. Sinopharm Haemophilia Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Haemophilia Drug Business of Sinopharm (2019-2024)
Table 95. Sinopharm Recent Developments
Table 96. Shanghai Raas Blood Products Basic Information List
Table 97. Shanghai Raas Blood Products Description and Business Overview
Table 98. Shanghai Raas Blood Products Haemophilia Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Haemophilia Drug Business of Shanghai Raas Blood Products (2019-2024)
Table 100. Shanghai Raas Blood Products Recent Developments
Table 101. China Biologic Products Basic Information List
Table 102. China Biologic Products Description and Business Overview
Table 103. China Biologic Products Haemophilia Drug Products, Services and Solutions
Table 104. Revenue (US$ Million) in Haemophilia Drug Business of China Biologic Products (2019-2024)
Table 105. China Biologic Products Recent Developments
Table 106. Hualan Bio Basic Information List
Table 107. Hualan Bio Description and Business Overview
Table 108. Hualan Bio Haemophilia Drug Products, Services and Solutions
Table 109. Revenue (US$ Million) in Haemophilia Drug Business of Hualan Bio (2019-2024)
Table 110. Hualan Bio Recent Developments
Table 111. CGE Healthcare Basic Information List
Table 112. CGE Healthcare Description and Business Overview
Table 113. CGE Healthcare Haemophilia Drug Products, Services and Solutions
Table 114. Revenue (US$ Million) in Haemophilia Drug Business of CGE Healthcare (2019-2024)
Table 115. CGE Healthcare Recent Developments
Table 116. Sinocelltech Group Basic Information List
Table 117. Sinocelltech Group Description and Business Overview
Table 118. Sinocelltech Group Haemophilia Drug Products, Services and Solutions
Table 119. Revenue (US$ Million) in Haemophilia Drug Business of Sinocelltech Group (2019-2024)
Table 120. Sinocelltech Group Recent Developments
Table 121. Shanxi Kangbao Biological Basic Information List
Table 122. Shanxi Kangbao Biological Description and Business Overview
Table 123. Shanxi Kangbao Biological Haemophilia Drug Products, Services and Solutions
Table 124. Revenue (US$ Million) in Haemophilia Drug Business of Shanxi Kangbao Biological (2019-2024)
Table 125. Shanxi Kangbao Biological Recent Developments
Table 126. CTTQ Basic Information List
Table 127. CTTQ Description and Business Overview
Table 128. CTTQ Haemophilia Drug Products, Services and Solutions
Table 129. Revenue (US$ Million) in Haemophilia Drug Business of CTTQ (2019-2024)
Table 130. CTTQ Recent Developments
Table 131. GC Biopharma Basic Information List
Table 132. GC Biopharma Description and Business Overview
Table 133. GC Biopharma Haemophilia Drug Products, Services and Solutions
Table 134. Revenue (US$ Million) in Haemophilia Drug Business of GC Biopharma (2019-2024)
Table 135. GC Biopharma Recent Developments
Table 136. Belief BioMed Basic Information List
Table 137. Belief BioMed Description and Business Overview
Table 138. Belief BioMed Haemophilia Drug Products, Services and Solutions
Table 139. Revenue (US$ Million) in Haemophilia Drug Business of Belief BioMed (2019-2024)
Table 140. Belief BioMed Recent Developments
Table 141. AryoGen Pharmed Basic Information List
Table 142. AryoGen Pharmed Description and Business Overview
Table 143. AryoGen Pharmed Haemophilia Drug Products, Services and Solutions
Table 144. Revenue (US$ Million) in Haemophilia Drug Business of AryoGen Pharmed (2019-2024)
Table 145. AryoGen Pharmed Recent Developments
Table 146. GENERIUM Basic Information List
Table 147. GENERIUM Description and Business Overview
Table 148. GENERIUM Haemophilia Drug Products, Services and Solutions
Table 149. Revenue (US$ Million) in Haemophilia Drug Business of GENERIUM (2019-2024)
Table 150. GENERIUM Recent Developments
Table 151. LFB SA Basic Information List
Table 152. LFB SA Description and Business Overview
Table 153. LFB SA Haemophilia Drug Products, Services and Solutions
Table 154. Revenue (US$ Million) in Haemophilia Drug Business of LFB SA (2019-2024)
Table 155. LFB SA Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Haemophilia Drug Downstream Customers
Table 159. Haemophilia Drug Distributors List
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
Table 163. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Haemophilia Drug Product Picture
Figure 2. Global Haemophilia Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Haemophilia Drug Sales Value (2019-2030) & (US$ Million)
Figure 4. Haemophilia Drug Report Years Considered
Figure 5. Global Haemophilia Drug Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Haemophilia Drug Revenue in 2023
Figure 7. Haemophilia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Blood-derived Coagulation Factor Picture
Figure 9. Recombinant Coagulation Factor Picture
Figure 10. Global Haemophilia Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Haemophilia Drug Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Haemophilia A
Figure 13. Product Picture of Haemophilia B
Figure 14. Product Picture of Others
Figure 15. Global Haemophilia Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Haemophilia Drug Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Haemophilia Drug Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Haemophilia Drug Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Haemophilia Drug Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Haemophilia Drug Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Haemophilia Drug Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Haemophilia Drug Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Haemophilia Drug Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Haemophilia Drug Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Haemophilia Drug Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Haemophilia Drug Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Haemophilia Drug Sales Value (%), (2019-2030)
Figure 28. United States Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 34. China Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 36. China Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 46. India Haemophilia Drug Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Haemophilia Drug Sales Value by Type (%), 2023 VS 2030
Figure 48. India Haemophilia Drug Sales Value by Application (%), 2023 VS 2030
Figure 49. Haemophilia Drug Industrial Chain
Figure 50. Haemophilia Drug Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
